FindTrial
Sign In

Clinical study protocol of sarcopenia in hemodialysis patients

Construction and application of clinical intelligent risk assessment system for maintenance hemodialysis patients with sarcopenia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051111
Enrollment
Unknown
Registered
2021-09-13
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney diseases

Interventions

case series:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Study population: maintenance hemodialysis patients; 2. Chronic kidney disease 5D stage (eGFR calculated by MDRD formula = 18 years; 5. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those with a pacemaker; major disability or mental illness; unable to cooperate with the investigation; 2. Malignant tumors that affect survival, symptomatic cardiopulmonary diseases, skeletal muscle system deformities, or motor dysfunction; 3. Poor compliance, unable to treat according to the plan; 4. Participate in other studies.

Design outcomes

Primary

MeasureTime frame
Grip strength;6 meter walk test;Body composition analysis;—

Secondary

MeasureTime frame
Micro-Nutrition Assessment Method;Mini-Mental State Examination;Self-rating Depression Scale;Activities of daily living;Montreal Cognitive Assessment;Barthel Index;—

Countries

China

Contacts

Public ContactYuan Huaihong

West China Hospital, Sichuan University

1609136873@qq.com+86 18980606926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 6, 2026